Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1986-11-12
1988-10-18
Lee, Mary C.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546 83, A61K 3147, C07D51304
Patent
active
047788119
ABSTRACT:
It has been found that 2-methyl-thiazolo[4,5-c]quinoline and pharmaceutically acceptable acid addition salts and hydrates thereof possess valuable central nervous depressive properties being different from those of benzodiazepines. The invention relates to pharmaceutical compositions comprising as active ingredient 2-methyl-thiazolo[4,5-c]quinoline of the Formula I ##STR1## or a pharmaceutically acceptable acid addition salt or hydrate thereof.
REFERENCES:
patent: 4666916 (1987-05-01), Schneider
Chemical Abstracts, vol. 60, Abst. No. 694d, 1964.
JACS, vol. 69, 1947, pp. 365-371.
Berenyi nee Poldermann Edit
Budai nee Simonyi Katalin
Furts Zsuzsa
Knoll Berta
Knoll Jozsef
Egis Gyogyszergyar
Lee Mary C.
Northington Zinna
LandOfFree
Pharmaceutical compositions of 2-methyl-thiazolo[4,5-c]quinoline does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical compositions of 2-methyl-thiazolo[4,5-c]quinoline, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical compositions of 2-methyl-thiazolo[4,5-c]quinoline will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1195177